a16z Capital Management, L.L.C. reported 19 equity positions with a combined reported value of $14.21B in its Q2 2026 Form 13F filing. The ten largest of those positions account for 99.4%of the filing’s reported value.
| # | Security | CUSIP | Class | Reported value | Shares | Weight |
|---|---|---|---|---|---|---|
| 1 | SPACE EXPLORATION TECHN CORP | 84615Q103 | CLASS A COM STK | $12.79B | 74.86M | 89.97% |
| 2 | NAVAN INC | 639193101 | CL A | $645.4M | 28.22M | 4.54% |
| 3 | REVOLUTION MEDICINES INC | 76155X100 | COM | $172.5M | 921K | 1.21% |
| 4 | META PLATFORMS INC | 30303M102 | CL A | $119.7M | 213K | 0.84% |
| 5 | FIGMA INC | 316841105 | CLASS A COM STK | $108.2M | 5.98M | 0.76% |
| 6 | BIOAGE LABS INC | 09077V100 | COM | $79.2M | 3.23M | 0.56% |
| 7 | BLOCK INC | 852234103 | CL A | $77.3M | 1.02M | 0.54% |
| 8 | ERASCA INC | 29479A108 | COM | $52.4M | 2.86M | 0.37% |
| 9 | MAZE THERAPEUTICS INC | 578784100 | COM | $50.8M | 1.70M | 0.36% |
| 10 | DAMORA THERAPEUTICS INC | 36322Q206 | COM NEW | $32.2M | 1.24M | 0.23% |
The full 19-position filing, quarter-over-quarter position changes, concentration analysis and cross-fund security search are in the Fund Tracker dashboard.
Open Fund TrackerRock Group holds a16z Capital Management, L.L.C.’s 13F filings for Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024. Period-over-period comparison — positions added, exited and resized — is available in the dashboard.
Browse all 13F filers on file, or read the Fund Tracker documentation for what Form 13F does and does not disclose.